Istari Oncology
Dr. Sandor has 18 years of experience in the pharmaceutical and biotechnology industries. Prior to its acquisition by Pfizer, Dr. Sandor was Chief Medical Officer at Array BioPharma. Previously, he was Senior Vice President for Global Clinical Development at Incyte and Vice President and Chief Medical Officer for Oncology at Biogen Idec. He has also held positions of increasing responsibility in oncology product development at AstraZeneca. Dr. Sandor received his MD, CM from McGill University in Montreal, Canada, and completed Fellowship in Medical Oncology at the National Institutes of Health in Bethesda, Maryland.
This person is not in the org chart
This person is not in any offices
Istari Oncology
Istari Oncology, Inc. is a clinical-stage biotechnology company focused on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors.